跳至主要内容
临床试验/NCT01860677
NCT01860677已完成不适用

The Effects of Cranial Electrotherapy Stimulation (CES) on Brain Function, Brain Chemistry and Mood: An fMRI/MRS Study

Mclean Hospital1 个研究点 分布在 1 个国家目标入组 8 人开始时间: 2010年5月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
8
试验地点
1
主要终点
BOLD fMRI (Neural Activation Patterns/Brain Function) Among Participants Who Completed Both Active and Sham Stimulation Visits

研究概览

简要总结

Document whether the Fischer Wallace Cranial Stimulator produces any measurable changes in brain activity.

详细描述

The advent of an appreciation that alternative and complementary practices can have some beneficial effect on health has prompted the question of whether there are empirical measures of improvement that do not rely solely on subjective reports. The present study proposes to explore whether transcranial stimulation (or cranial electrotherapy stimulation; CES) using an FDA-approved device can alter brain function, mood and responses to cognitive tasks.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
21 Years 至 55 Years(Adult)
性别
All
接受健康志愿者
是

入选标准

  • •21 to 55 years old
  • •Otherwise physically healthy (normal physical exam, ECG, blood and urine chemistries)
  • •Female participants must use medically approved method of contraception. If barrier method is used, they must agree to using two methods simultaneously (e.g., diaphragm and condom).
  • •If on antidepressant or antianxiety medication, must be on a stable prescription regimen with no intentions to change drugs or dose during the next 11 weeks.

排除标准

  • •Opiate maintenance (e.g., methadone or buprenorphine)
  • •Drug use (other than nicotine, alcohol, or marihuana) greater than 50 lifetime uses.
  • •Meets criteria for current drug abuse or dependence (other than nicotine, alcohol, or marihuana). Past abuse/dependence (greater than 3 years) is acceptable.
  • •Meets criteria for alcohol dependence. Past abuse/dependence (greater than 3 years) is acceptable. They may meet criteria for alcohol abuse.
  • •Physical health problems
  • •History of significant cardiac problems
  • •History of seizures
  • •Pregnancy
  • •Persons with a demand-type cardiac pacemaker
  • •Persons receiving vagus nerve simulation
  • •Persons receiving deep brain stimulation
  • •Participants cannot have any conditions that are contraindicated for MRI

研究组 & 干预措施

Active stimulation

Active Comparator

The Fisher Wallace Cranial Stimulator device generates micro currents of electricity using a patented series of radio frequencies. The device has been designated by the FDA to be minimally invasive and has FDA approval to be used to reduce symptoms associated with anxiety, depression, pain and insomnia. The unit is locked at the factory to deliver a maximal output of 4 mA of current and has a timer that prevents it from staying on longer than 20 minutes. Current will be limited to a maximum of 2 mA.

干预措施: Fisher Wallace Cranial Stimulator (Device)

Sham stimulation

Placebo Comparator

Participants are outfitted with a device that is identical to the Fisher Wallace Cranial Stimulator in appearance but does not deliver any current.

干预措施: Fisher Wallace Cranial Stimulator (Device)

结局指标

主要结局

BOLD fMRI (Neural Activation Patterns/Brain Function) Among Participants Who Completed Both Active and Sham Stimulation Visits

时间窗: within 30 minutes after CES treatment concluded; pre-treatment is at least 20 minutes before end of treatment

Quantitative changes in neural activation patterns during task performance as measured by BOLD functional MRI from 20 minutes of CES compared to pre-treatment. The coupling ratio is defined as the percent change in the cerebral blood flow divided by the percent change in the cerebral metabolic rate of oxygen consumption.

次要结局

  • Change in Positive and Negative Affect Schedule (PANAS) in Active Stimulation Arm(within 30 minutes after CES treatment concluded; pre-treatment is at least 20 minutes before end of treatment)
  • Change in Visual Analogue Scale (VAS) in Active Stimulation Arm(within 30 minutes after 1-day CES treatment concluded; pre-treatment is at least 20 minutes before end of treatment)
  • BOLD fMRI (Neural Activation Patterns/Brain Function) in Active Stimulation Arm Only(within 30 minutes after CES treatment concluded; pre-treatment is at least 20 minutes before end of treatment)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Scott Lukas

Director, McLean Imaging Center

Mclean Hospital

研究点 (1)

Loading locations...

相似试验